# Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

> **NCT03633799** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Sebela Women's Health Inc.** · enrollment: 1620 (actual)

## Conditions studied

- Women at Risk for Pregnancy

## Interventions

- **DRUG:** VeraCept

## Key facts

- **NCT ID:** NCT03633799
- **Lead sponsor:** Sebela Women's Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-22
- **Primary completion:** 2022-09-22
- **Final completion:** 2027-09-22
- **Target enrollment:** 1620 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633799, "Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03633799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*